HK1214956A1 - 穩定的腸胃外 組合物 - Google Patents

穩定的腸胃外 組合物

Info

Publication number
HK1214956A1
HK1214956A1 HK16102952.4A HK16102952A HK1214956A1 HK 1214956 A1 HK1214956 A1 HK 1214956A1 HK 16102952 A HK16102952 A HK 16102952A HK 1214956 A1 HK1214956 A1 HK 1214956A1
Authority
HK
Hong Kong
Prior art keywords
dnj
compositions
stable parenteral
parenteral
stable
Prior art date
Application number
HK16102952.4A
Other languages
English (en)
Inventor
亨.査爾
謝爾蓋.特斯勒
繼平.楊
恩里克.迪隆
Original Assignee
Amicus Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amicus Therapeutics Inc filed Critical Amicus Therapeutics Inc
Publication of HK1214956A1 publication Critical patent/HK1214956A1/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/45Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
HK16102952.4A 2013-01-09 2016-03-15 穩定的腸胃外 組合物 HK1214956A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361750677P 2013-01-09 2013-01-09
US201361914839P 2013-12-11 2013-12-11
PCT/US2014/010891 WO2014110270A1 (en) 2013-01-09 2014-01-09 Stable parenteral dnj compositions

Publications (1)

Publication Number Publication Date
HK1214956A1 true HK1214956A1 (zh) 2016-08-12

Family

ID=51167373

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16102952.4A HK1214956A1 (zh) 2013-01-09 2016-03-15 穩定的腸胃外 組合物

Country Status (9)

Country Link
US (2) US9827189B2 (zh)
EP (1) EP2943200B9 (zh)
CN (1) CN104918619B (zh)
AU (2) AU2014205378B2 (zh)
CA (1) CA2897432A1 (zh)
ES (1) ES2779006T3 (zh)
HK (1) HK1214956A1 (zh)
MX (1) MX2015008837A (zh)
WO (1) WO2014110270A1 (zh)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2015008837A (es) * 2013-01-09 2015-10-14 Amicus Therapeutics Inc Composiciones parenterales estables de dnj.
MX2018012902A (es) 2016-04-21 2019-06-06 Baylor College Medicine Composiciones y métodos para el tratamiento de trastornos de almacenamiento lisosomal y trastornos caracterizados por disfunción lisosomal.
KR20200004414A (ko) * 2017-05-15 2020-01-13 아미쿠스 세라퓨틱스, 인코포레이티드 재조합 인간 산 알파-글루코시다제
EP3996696A1 (en) 2019-07-09 2022-05-18 Genethon Treatment of glycogen storage disease (gsd)
CN111965278A (zh) * 2020-08-07 2020-11-20 广西壮族自治区蚕业技术推广站 一种检测桑枝中1-脱氧野尻霉素含量的试剂盒及方法
WO2022227287A1 (zh) * 2021-04-25 2022-11-03 中南大学 Dnj及其衍生物在制备预防和/或治疗肺动脉高压药物中的应用
EP4349334A1 (en) 2022-10-07 2024-04-10 Theranexus Palatable liquid solution containing high concentration of miglustat

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6291657B1 (en) * 1993-05-13 2001-09-18 Monsanto Company Deoxygalactonojirimycin derivatives
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
CN101355971A (zh) * 2005-05-17 2009-01-28 阿米库斯治疗学公司 使用1-去氧野尻霉素衍生物治疗庞皮病的方法
ES2572148T3 (es) * 2005-05-17 2016-05-30 Amicus Therapeutics Inc Un método para el tratamiento de la enfermedad de Pompe usando 1-desoxinojirimicina y derivados
US20100119502A1 (en) * 2008-11-11 2010-05-13 Amicus Therapeutics, Inc. Therapy regimens, dosing regimens and stable medicaments for the treatment of pompe disease
WO2011103114A1 (en) 2010-02-17 2011-08-25 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
GB201006434D0 (en) 2010-04-19 2010-06-02 Summit Corp Plc Novel iminosugar combinations
KR20230066482A (ko) * 2012-03-07 2023-05-15 아미쿠스 세라퓨틱스, 인코포레이티드 폼페병의 치료를 위한 고농도 알파-글루코시다제 조성물
MX2015008837A (es) * 2013-01-09 2015-10-14 Amicus Therapeutics Inc Composiciones parenterales estables de dnj.

Also Published As

Publication number Publication date
US9827189B2 (en) 2017-11-28
AU2014205378A1 (en) 2015-07-23
US10117830B2 (en) 2018-11-06
WO2014110270A1 (en) 2014-07-17
AU2018217271A1 (en) 2018-09-06
EP2943200B9 (en) 2020-07-22
EP2943200A1 (en) 2015-11-18
US20180078497A1 (en) 2018-03-22
EP2943200A4 (en) 2016-05-18
CN104918619A (zh) 2015-09-16
MX2015008837A (es) 2015-10-14
AU2014205378B2 (en) 2018-08-30
US20150352042A1 (en) 2015-12-10
CA2897432A1 (en) 2014-07-17
ES2779006T3 (es) 2020-08-13
EP2943200B1 (en) 2019-12-18
CN104918619B (zh) 2019-04-02

Similar Documents

Publication Publication Date Title
SG11201602596UA (en) Stabilized efinaconazole compositions
GB201304662D0 (en) Compositions
GB201319525D0 (en) Composition
EP2889350A4 (en) ADHESIVE COMPOSITION
GB201315559D0 (en) Sweetener compositions
GB201315558D0 (en) Sweetener compositions
GB201608461D0 (en) Compositions
HK1214088A1 (zh) 油脂組合物
HUE044039T2 (hu) Biokatalitikus készítmény
EP3006525A4 (en) ASPHALT-URETHANE COMPOSITION
HK1214956A1 (zh) 穩定的腸胃外 組合物
GB201319540D0 (en) Composition
GB201318489D0 (en) Composition
GB201317388D0 (en) Composition
GB201320919D0 (en) Composition
GB201306984D0 (en) Composition
EP3066178A4 (en) GREASE COMPOSITION
GB201322772D0 (en) Composition
GB201320303D0 (en) Composition
GB201319538D0 (en) Composition
GB201317196D0 (en) Composition
GB201307622D0 (en) Composition
GB201316463D0 (en) Novel compositions
ZA201505650B (en) New compositions
GB201420672D0 (en) Composition